Literature DB >> 2708326

Estrogen treatment increases phospholipid transfer activities in chicken liver.

A E Rusiñol1, B Bloj.   

Abstract

The effect of subcutaneous beta-estradiol injection on liver phosphatidylcholine, phosphatidylethanolamine and phosphatidylinositol transfer activity of immature chicken has been determined. The estrogen administration significantly enhanced the transfer activity of both phosphatidylcholine (100%), phosphatidylethanolamine (160%), and phosphatidylinositol (150%). In vivo experiments revealed that the hormone-induced changes in liver lipid transfer activity were sensitive to a protein synthesis inhibitor, cycloheximide. A partial characterization of liver protein transfer on Sephacryl S-200 showed that multiple transfer proteins are involved in the beta-estradiol effect. This is the first time that hormonal modulation of phospholipid transfer activities is described, and the results suggest that the hepatic phospholipid transfer activities might be involved in the biosynthesis of plasma lipoproteins in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2708326

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  The presence and subcellular distribution of sterol carrier protein 2 in embryonic-chick tissues.

Authors:  M P Reinhart; S J Avart; T O Dobson; T A Foglia
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

2.  Significant association of estrogen receptor binding site variation with bipolar disorder in females.

Authors:  Lisette Graae; Robert Karlsson; Silvia Paddock
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

3.  Dynamic Expression Profile, Regulatory Mechanism and Correlation with Egg-laying Performance of ACSF Gene Family in Chicken (Gallus gallus).

Authors:  Weihua Tian; Hang Zheng; Liyu Yang; Hong Li; Yadong Tian; Yanbin Wang; Shijie Lyu; Gudrun A Brockmann; Xiangtao Kang; Xiaojun Liu
Journal:  Sci Rep       Date:  2018-05-31       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.